Stay updated with breaking news from Nasdaq Spry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) insider Sarina Tanimoto sold 100,000 shares of the company’s stock in a transaction dated Tuesday, April 16th. The shares were sold at an average price of $9.28, for a total transaction of $928,000.00. Following the completion of the transaction, the insider now directly owns 1,647,447 shares in […]
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) insider Sarina Tanimoto sold 100,000 shares of the firm’s stock in a transaction dated Tuesday, April 16th. The shares were sold at an average price of $9.28, for a total transaction of $928,000.00. Following the transaction, the insider now directly owns 1,647,447 shares in the company, valued […]
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) insider Sarina Tanimoto sold 2,343 shares of the stock in a transaction on Friday, March 22nd. The shares were sold at an average price of $9.02, for a total value of $21,133.86. Following the completion of the transaction, the insider now owns 1,745,082 shares of the company’s […]
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) shares reached a new 52-week high during trading on Tuesday . The stock traded as high as $9.75 and last traded at $9.73, with a volume of 978686 shares trading hands. The stock had previously closed at $9.13. Analyst Ratings Changes Several analysts have issued reports on […]
ARS Pharmaceuticals (NASDAQ:SPRY – Get Free Report) was upgraded by equities research analysts at William Blair from a “market perform” rating to an “outperform” rating in a report released on Tuesday, MarketBeat Ratings reports. Separately, Wedbush increased their price target on ARS Pharmaceuticals from $5.00 to $13.00 and gave the stock an “outperform” rating in […]